Clinical Trials

ClinicalTrials.gov registrations across deep tech.

Showing 24 of 19,428 clinical trials

Therapeutic Strategies to Reduce Endothelial Ischemia-reperfusion Injury with Metabolic Syndrome: a Combination Approach with Lactate Administration and Ischemic Preconditioning

NCT06825143Starts in 26 days

EARLY_PHASE1NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Gary Van Guilder

Source: ClinicalTrials.gov · Synced about 2 months ago

Improving Secure Storage of Firearms to Reduce Suicide Deaths: A Hybrid Type 1 Implementation Effectiveness Randomized Controlled Trial of the Family Firearms Secure Storage Training (FFAST) Intervention

NCT07692854Starts in 26 days

NANOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: VA Office of Research and Development

Source: ClinicalTrials.gov · Synced about 2 months ago

Investigation of Mitomycin C PIPAC - FOLFIRI Combination for Unresectable Appendiceal or Colorectal Peritoneal Metastases Treatment (IMPACT): A Multicenter, Randomized, Open-Label, Phase 3 Trial

NCT07271355Starts in 26 days

PHASE3NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: City of Hope Medical Center

Source: ClinicalTrials.gov · Synced 4 days ago

Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Sinusitis)

NCT07732699Starts in 26 days

PHASE4NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Nader Shaikh

Source: ClinicalTrials.gov · Synced 4 days ago

Evaluating the Feasibility of a Survivin Peptide Vaccine (SurVaxM) as an Interception Agent in Patients at High Risk for Lung Cancer

NCT07169617Starts in 26 days

PHASE2NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: National Cancer Institute (NCI)

Source: ClinicalTrials.gov · Synced 4 days ago

Feasibility Trial of a Remotely-Delivered Mindfulness-Based Intervention for Adolescents With Migraine

NCT07513662Starts in 26 days

NANOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: University of Colorado Denver

Source: ClinicalTrials.gov · Synced 4 days ago

The Effects of SGLT2 Inhibition on Vascular Health and Physical Function in Veterans With CKD

NCT07060417Starts in 26 days

PHASE2NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: VA Office of Research and Development

Source: ClinicalTrials.gov · Synced 4 days ago

Efficacy of Integrating Next Generation Sequencing for Treatment of Surgical Site Infection After Fracture Fixation: A Multicenter Randomized Control Trial

NCT07458230Starts in 26 days

PHASE3NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Sponsor not in directory

Source: ClinicalTrials.gov · Synced about 2 months ago

HAIQU (Hospital AIr QUality): Breathing Life Into Patient Care

NCT07670117Starts in 26 days

NANOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Sponsor not in directory

Source: ClinicalTrials.gov · Synced about 2 months ago

Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients in Gout (Pharm-UP) Study

NCT06887452Starts in 26 days

NANOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: VA Office of Research and Development

Source: ClinicalTrials.gov · Synced about 2 months ago

A Pre-Market, Multicentre, Prospective, Open-Label, Within-Subject, Non-Randomised, Interventional Study Examining Acceptability of Auditory Implant Fitting Software Technologies

NCT07763873Starts in 26 days

NANOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Cochlear

Source: ClinicalTrials.gov · Synced 4 days ago

A Multicenter Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, and Efficacy of the NaPi2B Antibody-Drug Conjugate TUB-040 in Patients With Recurrent or Progressive Uterine Endometrial Cancer After Platinum-Based Chemotherapy and Immune Checkpoint Inhibitor Therapy

NCT07743541Starts in 26 days

PHASE1PHASE2NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Tubulis GmbH

Source: ClinicalTrials.gov · Synced 4 days ago

Movement and Memory After Breast Cancer: The MAMA Trial

NCT07331077Starts in 26 days

NANOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Sponsor not in directory

Source: ClinicalTrials.gov · Synced about 2 months ago

An Open Label Study to Treat Post-Traumatic Stress in Frontline Healthcare Workers and First Responders Using MDMA-Assisted Therapy

NCT05455996Starts in 26 days

PHASE2NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Nautilus Sanctuary

Source: ClinicalTrials.gov · Synced about 2 months ago

A Phase 0/1 Study of NST-628 in Participants With Recurrent Grade 4 Glioma Scheduled for Resection to Evaluate Central Nervous System (CNS) Penetration With Pharmacodynamic (PD) Triggered Expansion Cohort

NCT07784985Starts in 26 days

EARLY_PHASE1NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Nader Sanai

Source: ClinicalTrials.gov · Synced 4 days ago

Comparative Effectiveness of Available Treatments for Sinus and Ear Infections in Children (Acute Otitis Media)

NCT07730814Starts in 26 days

PHASE4NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Nader Shaikh

Source: ClinicalTrials.gov · Synced 4 days ago

Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Progressive Idiopathic Pulmonary Fibrosis (STRIVE II)

NCT07674745Starts in 26 days

PHASE2NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: University of Alabama at Birmingham

Source: ClinicalTrials.gov · Synced about 2 months ago

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety And Efficacy Of Rimegepant For Endometriosis-Associated Pain

NCT07795125Starts in 25 days

PHASE2NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Mayo Clinic

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase III, Randomized, Open-label Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy as First-Line Therapy in Patients With EGFR-Mutant Locally Advanced or Metastatic Non-small Cell Lung Cancer

NCT07680790Starts in 25 days

PHASE3NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Bristol-Myers Squibb

Source: ClinicalTrials.gov · Synced 4 days ago

A Phase 1 Study to Assess Safety and Tolerability of Amicidin-β Topical Solution in Adult Patients Undergoing Interventional Management of a Surgical or Traumatic Wound Infection

NCT07379684Starts in 25 days

PHASE1RECRUITINGINTERVENTIONAL

Sponsor: Macro Biologics, Inc.

Source: ClinicalTrials.gov · Synced 4 days ago

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Study of Bionetide for the Treatment of Girls and Women With Rett Syndrome

NCT06840496Starts in 25 days

PHASE3RECRUITINGINTERVENTIONAL

Sponsor: Biomed Industries, Inc.

Source: ClinicalTrials.gov · Synced about 2 months ago

A Randomized, 2-Arm Study to Evaluate the Efficacy and Safety of CRB-701 Compared With Investigator's Choice of Capecitabine, Cetuximab, or Docetaxel in Participants With Recurrent or Metastatic Oropharyngeal Squamous Cell Carcinoma Previously Treated With Platinum-based Chemotherapy and a PD-(L)1 Inhibitor

NCT07768189Starts in 15 days

PHASE3NOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Corbus Pharmaceuticals Inc.

Source: ClinicalTrials.gov · Synced 4 days ago

Rethinking Early Airway Clearence Therapies

NCT07696338Starts in 10 days

NANOT_YET_RECRUITINGINTERVENTIONAL

Sponsor: Nicole Hamblett

Source: ClinicalTrials.gov · Synced about 2 months ago

A Phase 1/2a, Open-label, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of BMS-986528 in Participants With Refractory Rheumatoid Arthritis

NCT07412704Starts in 10 days

PHASE1PHASE2RECRUITINGINTERVENTIONAL

Sponsor: Bristol-Myers Squibb

Source: ClinicalTrials.gov · Synced 4 days ago

Load more (24)

Trial data sourced from ClinicalTrials.gov, a service of the U.S. National Library of Medicine.